Es gab 50 kürzliche Insider-Transaktionen für Fusion Pharmaceuticals Inc. (FUSN), darunter 32 Käufe und 14 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $1.35M und die gesamten Insider-Verkäufe auf $1.35M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Cagnoni Pablo J, Duncan Barbara Gayle, Leamon Christopher P. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — FUSN
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2024-06-04 |
Cagnoni Pablo J |
Director |
Aktienrückgabe |
141,011 |
$2.35 |
$331.38K |
- |
| 2024-06-04 |
Duncan Barbara Gayle |
Director |
Aktienrückgabe |
17,000 |
$4.64 |
$78.88K |
- |
| 2024-06-04 |
Leamon Christopher P |
Chief Scientific Officer |
Aktienrückgabe |
63,700 |
- |
- |
- |
| 2024-06-04 |
Meek David D. |
Director |
Aktienrückgabe |
34,000 |
$4.16 |
$141.44K |
- |
| 2024-06-04 |
Crowley John J |
Chief Financial Officer |
Aktienrückgabe |
63,700 |
- |
- |
- |
| 2024-06-04 |
Gannon Steven |
Director |
Aktienrückgabe |
17,000 |
$4.64 |
$78.88K |
- |
| 2024-06-04 |
Bergstrom Donald A |
Director |
Aktienrückgabe |
34,000 |
$10.59 |
$360.06K |
- |
| 2024-06-04 |
Valliant John |
Chief Executive Officer |
Aktienrückgabe |
192,200 |
- |
- |
- |
| 2024-06-04 |
Burak Eric |
Chief Technology Officer |
Aktienrückgabe |
63,700 |
- |
- |
- |
| 2024-06-04 |
Lee Philina |
Director |
Aktienrückgabe |
17,000 |
$4.64 |
$78.88K |
- |
| 2024-06-04 |
Bender Jeremy |
Director |
Aktienrückgabe |
34,000 |
$4.16 |
$141.44K |
- |
| 2024-06-04 |
Rawat Mohit |
President & Cbo |
Aktienrückgabe |
81,300 |
- |
- |
- |
| 2024-06-04 |
Bobilev Dmitri |
Chief Medical Officer |
Aktienrückgabe |
91,000 |
- |
- |
- |
| 2024-06-04 |
Bitetti Teresa Marie |
Director |
Aktienrückgabe |
34,000 |
$4.16 |
$141.44K |
- |
| 2024-01-04 |
Leamon Christopher P |
Chief Scientific Officer |
RSU-Zuteilung |
63,700 |
- |
- |
63,700 |
| 2024-01-04 |
Crowley John J |
Chief Financial Officer |
RSU-Zuteilung |
63,700 |
- |
- |
63,700 |
| 2024-01-04 |
Valliant John |
Chief Executive Officer |
RSU-Zuteilung |
192,200 |
- |
- |
192,200 |
| 2024-01-04 |
Burak Eric |
Chief Technology Officer |
RSU-Zuteilung |
63,700 |
- |
- |
63,700 |
| 2024-01-04 |
Rawat Mohit |
President & Cbo |
RSU-Zuteilung |
81,300 |
- |
- |
81,300 |
| 2024-01-04 |
Bobilev Dmitri |
Chief Medical Officer |
RSU-Zuteilung |
91,000 |
- |
- |
91,000 |
| 2023-10-16 |
Meek David D. |
Director |
Unbekannt |
- |
- |
- |
- |
| 2023-10-16 |
Meek David D. |
Director |
RSU-Zuteilung |
34,000 |
$4.16 |
$141.44K |
34,000 |
| 2023-10-16 |
Bender Jeremy |
Director |
Unbekannt |
- |
- |
- |
- |
| 2023-10-16 |
Bender Jeremy |
Director |
RSU-Zuteilung |
34,000 |
$4.16 |
$141.44K |
34,000 |
| 2023-10-16 |
Bitetti Teresa Marie |
Director |
Unbekannt |
- |
- |
- |
- |
| 2023-10-16 |
Bitetti Teresa Marie |
Director |
RSU-Zuteilung |
34,000 |
$4.16 |
$141.44K |
34,000 |
| 2023-08-31 |
Leamon Christopher P |
Chief Scientific Officer |
RSU-Zuteilung |
11,957 |
- |
- |
11,957 |
| 2023-08-31 |
Rawat Mohit |
President & Cbo |
RSU-Zuteilung |
12,843 |
- |
- |
12,843 |
| 2023-06-14 |
Cagnoni Pablo J |
Director |
RSU-Zuteilung |
17,000 |
$4.64 |
$78.88K |
17,000 |
| 2023-06-14 |
Duncan Barbara Gayle |
Director |
RSU-Zuteilung |
17,000 |
$4.64 |
$78.88K |
17,000 |
| 2023-06-14 |
Preston Heather |
Director |
RSU-Zuteilung |
17,000 |
$4.64 |
$78.88K |
17,000 |
| 2023-06-14 |
Khuong Chau Quang |
Director |
RSU-Zuteilung |
17,000 |
$4.64 |
$78.88K |
17,000 |
| 2023-06-14 |
Gannon Steven |
Director |
RSU-Zuteilung |
17,000 |
$4.64 |
$78.88K |
17,000 |
| 2023-06-14 |
Bergstrom Donald A |
Director |
RSU-Zuteilung |
17,000 |
$4.64 |
$78.88K |
17,000 |
| 2023-06-14 |
Lee Philina |
Director |
RSU-Zuteilung |
17,000 |
$4.64 |
$78.88K |
17,000 |
| 2023-01-05 |
Leamon Christopher P |
Chief Scientific Officer |
RSU-Zuteilung |
250,000 |
- |
- |
250,000 |
| 2023-01-05 |
Crowley John J |
Chief Financial Officer |
RSU-Zuteilung |
250,000 |
- |
- |
250,000 |
| 2023-01-05 |
Valliant John |
Chief Executive Officer |
RSU-Zuteilung |
500,000 |
- |
- |
500,000 |
| 2023-01-05 |
Burak Eric |
Chief Technology Officer |
RSU-Zuteilung |
250,000 |
- |
- |
250,000 |
| 2023-01-05 |
Rawat Mohit |
President and Cbo |
RSU-Zuteilung |
300,000 |
- |
- |
300,000 |
| 2022-11-11 |
Khuong Chau Quang |
Director |
RSU-Zuteilung |
42,093 |
$2.38 |
$100.18K |
42,093 |
| 2022-11-07 |
Bobilev Dmitri |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2022-11-07 |
Bobilev Dmitri |
Chief Medical Officer |
RSU-Zuteilung |
550,000 |
- |
- |
550,000 |
| 2022-08-11 |
Gannon Steven |
Director |
Informierter Kauf |
44,400 |
$2.03 |
$90.13K |
56,400 |
| 2022-06-14 |
Cagnoni Pablo J |
Director |
RSU-Zuteilung |
17,000 |
- |
- |
17,000 |
| 2022-06-14 |
Duncan Barbara Gayle |
Director |
RSU-Zuteilung |
17,000 |
- |
- |
17,000 |
| 2022-06-14 |
Preston Heather |
Director |
RSU-Zuteilung |
17,000 |
- |
- |
17,000 |
| 2022-06-14 |
Khuong Chau Quang |
Director |
RSU-Zuteilung |
17,000 |
$3.60 |
$61.2K |
17,000 |
| 2022-06-14 |
Gannon Steven |
Director |
RSU-Zuteilung |
17,000 |
$3.60 |
$61.2K |
17,000 |
| 2022-06-14 |
Bergstrom Donald A |
Director |
RSU-Zuteilung |
17,000 |
$3.60 |
$61.2K |
17,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall